Literature DB >> 6813184

Apolipoprotein localization and quantitation in the human intestine.

P H Green, J H Lefkowitch, R M Glickman, J W Riley, E Quinet, C B Blum.   

Abstract

Apolipoproteins B, A-I, and A-IV were localized in human intestinal epithelium using immunoperoxidase techniques. Staining was most obvious in villus tip cells. Lipid absorption resulted in an increase in intraepithelial staining for each apoprotein. The pattern for apo-B in the biopsy specimens taken after lipid absorption revealed a marked redistribution of staining to the intercellular spaces and an increase in the supranuclear staining of apo-A-I and apo-A-IV. After lipid absorption, staining appeared to extend further down the villus than in the fasting biopsy specimens. Quantitation of apo-A-I and apo-A-IV in isolated epithelial cells confirmed that the mass of these apoproteins increases in response to lipid absorption. Apolipoprotein B and apo-A-I were absent in the epithelium of 3 patients with abetalipoproteinemia while apo-A-IV was present in 2 patients. These studies demonstrate differences in the localization and quantitation of apoproteins in the villus-crypt unit as well as differences in the localization pattern of the different apoproteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813184

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Immunohistochemical localization of low density lipoprotein receptors in adrenal gland, liver, and intestine.

Authors:  L G Fong; E Bonney; J C Kosek; A D Cooper
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

2.  Genetic studies of human apolipoproteins. I. Polymorphism of apolipoprotein A-IV.

Authors:  M I Kamboh; R E Ferrell
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

3.  Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

Authors:  Andreas G Moraitis; Lita A Freeman; Robert D Shamburek; Robert Wesley; Wyndham Wilson; Cliona M Grant; Susan Price; Stephen Demosky; Seth G Thacker; Abdalrahman Zarzour; Ronald L Hornung; Frank Pucino; Gyorgy Csako; Cheryl Yarboro; Iain B McInnes; Takashi Kuroiwa; Dimitrios Boumpas; V Koneti Rao; Gabor G Illei; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2014-10-05       Impact factor: 4.766

4.  In gastroesophageal reflux disease, differential gene expression in the duodenum points towards enhanced chylomicron production and secretion.

Authors:  Durk R de Vries; José J M ter Linde; Ofke S van Boxel; Margot A van Herwaarden; Pierre Shephard; Michael M Geng; Matthijs P Schwartz; Melvin Samsom
Journal:  Dig Dis Sci       Date:  2012-02-16       Impact factor: 3.199

5.  Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.

Authors:  K J Lackner; J C Monge; R E Gregg; J M Hoeg; T J Triche; S W Law; H B Brewer
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

6.  Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior.

Authors:  K Aalto-Setälä; C L Bisgaier; A Ho; K A Kieft; M G Traber; H J Kayden; R Ramakrishnan; A Walsh; A D Essenburg; J L Breslow
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Enhanced synthesis of cholesterol and its precursors in jejunal mucosa in coeliac disease.

Authors:  M Vuoristo; T A Miettinen
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

8.  Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes.

Authors:  S Guilmeau; I Niot; J P Laigneau; H Devaud; V Petit; N Brousse; R Bouvier; L Ferkdadji; C Besmond; L P Aggerbeck; A Bado; M E Samson-Bouma
Journal:  Histochem Cell Biol       Date:  2007-06-29       Impact factor: 4.304

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.